114 related articles for article (PubMed ID: 29542427)
1. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
[TBL] [Abstract][Full Text] [Related]
2. An In Vitro and In Vivo Evaluation of the Effect of Relacorilant on the Activity of Cytochrome P450 Drug Metabolizing Enzymes.
Custodio JM; Donaldson KM; Hunt HJ
J Clin Pharmacol; 2021 Feb; 61(2):244-253. PubMed ID: 32869328
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes.
Bansal S; Paine MF; Unadkat JD
Drug Metab Dispos; 2022 Apr; 50(4):351-360. PubMed ID: 35115300
[TBL] [Abstract][Full Text] [Related]
4. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids.
Kamble SH; Sharma A; King TI; Berthold EC; León F; Meyer PKL; Kanumuri SRR; McMahon LR; McCurdy CR; Avery BA
Toxicol Lett; 2020 Feb; 319():148-154. PubMed ID: 31707106
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of the effects of 4-aminopyridine on cytochrome P450 enzymes.
Caggiano A; Blight A
J Drug Assess; 2013; 2(1):106-16. PubMed ID: 27536444
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition of human CYP1A2, CYP2D6, and CYP3A4 by six herbs commonly used in pregnancy.
Langhammer AJ; Nilsen OG
Phytother Res; 2014 Apr; 28(4):603-10. PubMed ID: 23843424
[TBL] [Abstract][Full Text] [Related]
7. In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine.
Chen Y; Liu L; Laille E; Kumar G; Surapaneni S
Cancer Chemother Pharmacol; 2010 Apr; 65(5):995-1000. PubMed ID: 20119716
[TBL] [Abstract][Full Text] [Related]
8. African Lettuce (Launaea taraxacifolia) Displays Possible Anticancer Effects and Herb-Drug Interaction Potential by CYP1A2, CYP2C9, and CYP2C19 Inhibition.
Thomford NE; Mkhize B; Dzobo K; Mpye K; Rowe A; Parker MI; Wonkam A; Skelton M; September AV; Dandara C
OMICS; 2016 Sep; 20(9):528-37. PubMed ID: 27631192
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of human cytochrome P450 enzymes by licoisoflavone B from Glycyrrhiza uralensis Fisch. ex DC.
Chen L; Nikolic D; Li G; Liu J; van Breemen RB
Toxicol Sci; 2023 Oct; 196(1):16-24. PubMed ID: 37535691
[TBL] [Abstract][Full Text] [Related]
10. Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
Kim HJ; Kim IS; Rehman SU; Ha SK; Nakamura K; Yoo HH
Bioorg Med Chem Lett; 2017 Apr; 27(8):1826-1830. PubMed ID: 28274629
[TBL] [Abstract][Full Text] [Related]
11. Studying the Inhibitory Effect of Quercetin and Thymoquinone on Human Cytochrome P450 Enzyme Activities.
Elbarbry F; Ung A; Abdelkawy K
Pharmacogn Mag; 2018 Jan; 13(Suppl 4):S895-S899. PubMed ID: 29491651
[TBL] [Abstract][Full Text] [Related]
12. Pungent ginger components modulates human cytochrome P450 enzymes in vitro.
Li M; Chen PZ; Yue QX; Li JQ; Chu RA; Zhang W; Wang H
Acta Pharmacol Sin; 2013 Sep; 34(9):1237-42. PubMed ID: 23770984
[TBL] [Abstract][Full Text] [Related]
13. Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies.
Qiu JX; Zhou ZW; He ZX; Zhang X; Zhou SF; Zhu S
Drug Des Devel Ther; 2015; 9():841-66. PubMed ID: 25733806
[TBL] [Abstract][Full Text] [Related]
14. Effect of tubeimoside I on the activity of cytochrome P450 enzymes in human liver microsomes.
Wang R; Zheng K; Liu Y; Ji S; Tang Y; Wang J; Jiang R
Xenobiotica; 2024 Feb; 54(2):57-63. PubMed ID: 38166553
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of major drug metabolizing CYPs by common herbal medicines used by HIV/AIDS patients in Africa-- implications for herb-drug interactions.
Awortwe C; Bouic PJ; Masimirembwa CM; Rosenkranz B
Drug Metab Lett; 2014 Jul; 7(2):83-95. PubMed ID: 24475926
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the drug-drug interaction and incompatibility mechanism between Aconitum carmichaelii Debx and Pinellia ternata (Thunb.) Breit.
Ge M; Ouyang H; Shang Y; Biu AM; Wu X; Li C; Zuo F; Zhu Y; Xue Z; Hao J; He J
J Ethnopharmacol; 2024 Aug; 330():118212. PubMed ID: 38636577
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Clinical Drug-Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach.
de Vries M; Bonsmann S; Pausch J; Sumner M; Birkmann A; Zimmermann H; Kropeit D
Clin Pharmacol Drug Dev; 2024 May; ():. PubMed ID: 38752475
[TBL] [Abstract][Full Text] [Related]
18. A Comparison of the In Vitro Inhibitory Effects of Thelephoric Acid and SKF-525A on Human Cytochrome P450 Activity.
Song M; Do H; Kwon OK; Yang EJ; Bae JS; Jeong TC; Song KS; Lee S
Biomol Ther (Seoul); 2014 Feb; 22(2):155-60. PubMed ID: 24753822
[TBL] [Abstract][Full Text] [Related]
19. Effects of an aqueous-ethanolic extract of ginger on cytochrome P450 enzyme-mediated drug metabolism.
Kim IS; Kim SY; Yoo HH
Pharmazie; 2012 Dec; 67(12):1007-9. PubMed ID: 23346764
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics.
Mukkavilli R; Gundala SR; Yang C; Donthamsetty S; Cantuaria G; Jadhav GR; Vangala S; Reid MD; Aneja R
PLoS One; 2014; 9(9):e108386. PubMed ID: 25251219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
